SEC Comment Letter 0000000000-24-001139 to Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc.
Date: Jan. 30, 2024 · CIK: 0001680367 · Accession: 0000000000-24-001139
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276677
Letter
United States securities and exchange commission logo January 30, 2024 Dr. Taylor Schreiber Chief Executive Officer Shattuck Labs, Inc. 500 W. 5th Street, Suite 1200 Austin, TX 78701 Re:Shattuck Labs, Inc. Registration Statement on Form S-3 Filed January 24, 2024 File No. 333-276677 Dear Dr. Taylor Schreiber: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Melanie Neary, Esq.
Show Raw Text
United States securities and exchange commission logo
January 30, 2024
Dr. Taylor Schreiber
Chief Executive Officer
Shattuck Labs, Inc.
500 W. 5th Street, Suite 1200
Austin, TX 78701
Re:Shattuck Labs, Inc.
Registration Statement on Form S-3
Filed January 24, 2024
File No. 333-276677
Dear Dr. Taylor Schreiber:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Melanie Neary, Esq.